Press "Enter" to skip to content

BAE Systems eyes more growth in 2021, confident on long-term

British defence company BAE Systems forecast another year of growth in 2021, helped by Germany's recent order for Typhoon jets and strong demand in its Electronic Systems unit, and was confident about its longer term outlook. BAE, which builds combat ships, submarines and fighter jets, said that underlying earnings per share would rise by between 3% and 5% in 2021. Two big acquisitions it made last year in the United States, its biggest market, would boost its higher-margin Electronic Systems unit, which provides flight controls, electronic warfare and surveillance capabilities, it said.

UK needs 100 billion pound push from Sunak’s budget, think tank says

British finance minister Rishi Sunak should follow the lead of the United States by announcing a 100 billion pound stimulus push in next week's budget to fuel an economic recovery from the COVID-19 pandemic, a think tank said on Thursday. Sunak, who is due to announce a new budget plan on March 3, has already racked up more than 280 billion pounds ($395 billion) in coronavirus spending and tax cuts, pushing Britain's borrowing to its highest since World War Two. The Resolution Foundation said Sunak should extend emergency support for businesses and workers and announce a new round of stimulus measures to alleviate unemployment, boost green investment and help retailers.

The United Kingdom Approved Second COVID-19 Vaccine

Dublin, Jan. 06, 2021 (GLOBE NEWSWIRE) -- ResearchAndMarkets.com published a new article on the COVID-19 vaccine industry "The United Kingdom Approved Second COVID-19 Vaccine" The United Kingdom has approved another COVID-19 vaccine, weeks after the country became the first to start vaccinating its citizens. The UK’s Medicines and Healthcare Products Regulatory Agency (MHRA) authorized Oxford University/AstraZeneca's vaccine, saying it met “strict standards of safety, quality and effectiveness.” The UK National Health Service has already vaccinated hundreds of thousands of patients with the Pfizer/BioNTech vaccine, and will continue to do so. The Oxford/AstraZeneca vaccine has a lower efficacy rate of 70 percent - in contrast to the Pfizer/BioNTech rate of 95 percent - but the Oxford/AstraZeneca vaccine is also cheaper and easier to store and transport. The Oxford/AstraZeneca vaccine can be stored at refrigerator temperatures, rather than requiring deep-freeze storage, making it the only viable vaccine in many developing countries where deep-freeze technology is not widespread. To get more information about COVID-19 vaccines and health care programmes, check out the following reports and workshops: COVID-19 Stem Cell Therapies Pipeline2020 Medical Tourism Index ReportGlobal Healthcare Licensing with China: China - Americas Most Recent 100 To see the full article and a list of related reports on the market, visit "The United Kingdom Approved Second COVID-19 Vaccine" About ResearchAndMarkets.com ResearchAndMarkets.com is the world's leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends. Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

United Kingdom Home Insurance Market Report 2021: COVID-19 a New Significant Market Driver for the £7 Billion Industry

Dublin, Jan. 06, 2021 (GLOBE NEWSWIRE) -- The "UK Home Insurance Market Report 2021" report has been added to ResearchAndMarkets.com's offering. This report looks at the domestic home/property insurance market, where home insurance is defined as insurance which covers individuals against the cost of repairing or rebuilding their home or replacing its contents. This report considers the size of the market, recent trends, the major players, forecast for the future and sets out the environmental framework in which insurance is sold today.2019/20 have been turbulent years for home insurance in terms of claims, significant mergers and divestments and changed underwriting capacity. The publisher estimates that home insurance gross written premiums (GWP) will reach around 7 billion in 2020, a rise of 2% compared with 2019. Predicting future premiums growth is very difficult at the moment given the uncertainties about when the effects of the COVID-19 pandemic will come to an end, and the pandemics final economic impact. Overall, the publisher expects to see no growth in GWP in 2021, however, growth will return after 2021. Key factors influencing the market today are: COVID-19 - This has had a range of impacts on the home insurance market. Key amongst these are more home working, which has reduced burglary and water damage claims but increased fire claims. It has also increased pressure on the finances of some families making it harder for them to afford home insurance. This has been mitigated, however, by FCA temporary measures to get insurers to offer flexibility on payments including payment deferrals. COVID-19 has also driven the adoption of IT systems by insurers, covering their internal operations and their direct to consumer distribution operations. This has accelerated the growing focus of the industry on using InsurTech to improve customer engagement and offer more competitive and tailored prices.The continued rise in household numbers and the recent growth in rented accommodationThe impact of adverse weather events and climate change on claims (e.g. claims for flooding and escape of water), including major storms at the end of 2019 and start of 2020The desire for home improvements among homeowners and modern construction techniques which are encouraging claims for escape of water and fireThe growing willingness of households to switch insurers to get lower premiumsThe FCA Market pricing study, which is set to outlaw price walking, introduce enhanced product governance rules and eventually stop auto-renewal being used as a barrier to switchingGrowing consolidation among insurers, which has seen Allianz (including LV= and Legal & General) emerge as the clear market leader. Key Topics Covered: EXECUTIVE SUMMARY Over 600 insurers with the direct sales route the most importantThe number of and type of households are prime market driversAs are weather, crime and building techniquesCOVID-19 a new significant market driverFCA Market Pricing StudyAllianz the new market leaderA market valued at over 7 billionLittle growth predicted in the future INTRODUCTION Abbreviations MARKET STRUCTURE Direct route or via price comparison websitesOver 600 insurersTwo main channels to market MARKET DEVELOPMENTS AND DRIVERS Almost 30 million homes to insureEight-in-ten householders own home insuranceOwnership more likely if the consumer is older and a homeownerLong-term change in housing tenureWeather and the environment major issuesNew building and home improvements increase risksCOVID-19Home insurance merges into HomeTechThe rise of Insurer Hosted pricingFlexible and On-demand home insuranceFinancial Conduct Authority's Market Pricing StudyInsurance Premium Tax hits premium costs THE KEY PLAYERS Allianz is now the clear market leaderAdmiral GroupAllianz Insurance/LV/Legal and GeneralAgeasAxa Insurance UK LtdAvivaBGL GroupCo-op GroupCovea Insurance plcDirect Line Groupesure GroupHastings GroupLloyds Banking GroupMarkerstudy GroupRSAZurich MARKET SIZE AND TRENDS A turbulent periodHome insurance market worth over 7 billion in GWPBut consumers spend less than this in a given year THE FUTURE InsurTech will continue to bring innovation to the industryThe potential for Open FinanceCOVID-19 will have long-term impacts.As will the FCA Market Review on pricingGWP predicted to rise by almost 5% ASSOCIATIONS Companies Mentioned Admiral GroupAgeasAllianz Insurance/LV/Legal and GeneralAvivaAxa Insurance UK LtdBGL GroupCo-op GroupCovea Insurance plcDirect Line Groupesure GroupHastings GroupLloyds Banking GroupMarkerstudy GroupRSAZurich For more information about this report visit https://www.researchandmarkets.com/r/y54uit Research and Markets also offers Custom Research services providing focused, comprehensive and tailored research. CONTACT:
CONTACT: ResearchAndMarkets.com
Laura Wood, Senior Press Manager
[email protected]
For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

Irish COVID-19 unemployment rate dipped to 20% before latest lockdown

Ireland's unemployment rate, including those receiving temporary COVID-19 jobless benefit, dipped to 20.4% in December when public health restrictions were relaxed for several weeks from 21% the previous month, data showed on Wednesday. Excluding those on the emergency Pandemic Unemployment Payment, 7.2% of the workforce were registered as unemployed in December, down from a revised 7.3% the previous month, the Central Statistics Office said.